Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $2.30B | $2.23B | $2.14B | $1.95B | $2.09B | $2.17B | $2.25B | $2.25B | $2.22B |
| Revenue growth | — | — | -2.8% | -4.2% | -8.9% | 7.1% | 4.0% | 3.7% | 0.1% | -1.3% |
| Gross profit | $1.16B | $1.13B | $1.03B | $967M | $881M | $951M | $881M | $941M | $956M | $925M |
| Gross margin | — | 49.0% | 46.2% | 45.1% | 45.2% | 45.6% | 40.5% | 41.8% | 42.4% | 41.6% |
| Operating income | — | — | — | $244M | $176M | $240M | $182M | $227M | $199M | $96.6M |
| Operating margin | — | — | — | 11.4% | 9.0% | 11.5% | 8.4% | 10.1% | 8.8% | 4.3% |
| Net income | $179M | $5.70M | $103M | -$372M | $67.6M | $118M | $99.5M | $115M | $98.6M | $25.4M |
| Net margin | — | 0.2% | 4.6% | -17.4% | 3.5% | 5.6% | 4.6% | 5.1% | 4.4% | 1.1% |
| EPS (diluted) | $2.99 | $0.10 | $1.90 | -$6.88 | $1.24 | $2.13 | $1.85 | $2.21 | $1.97 | $0.53 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $187M | $314M | $259M | $191M | $233M | $229M | $102M | -$216M | -$231M | $118M |
| Capital expenditures | $69.5M | $69.0M | $62.0M | $58.0M | $47.7M | $56.8M | $56.4M | $49.5M | $56.5M | $77.0M |
| Free cash flow | $117M | $245M | $197M | $133M | $185M | $172M | $45.6M | -$266M | -$288M | $41.4M |
| Share buybacks | $197M | $165M | $124M | $0.00 | $0.00 | $9.20M | $125M | $75.2M | $58.5M | $90.2M |
| Dividends paid | $0.00 | $0.00 | — | $0.00 | $0.00 | $25.6M | $32.6M | $31.5M | $30.7M | $29.3M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $739M | $503M | $266M | $342M | $365M | $479M | $189M | $216M | $209M | $226M |
| Total assets | $4.77B | $4.19B | $3.95B | $3.42B | $3.54B | $3.67B | $3.71B | $3.74B | $3.73B | $3.76B |
| Total liabilities | $2.94B | $2.45B | $2.21B | $2.12B | $2.11B | $2.09B | $2.25B | $2.20B | $2.15B | $2.20B |
| Long-term debt | $1.54B | $1.53B | $1.10B | $1.10B | $1.24B | $1.23B | $1.39B | $1.36B | $1.27B | $1.38B |
| Shareholders' equity | $1.83B | $1.74B | $1.74B | $1.30B | $1.44B | $1.59B | $1.47B | $1.54B | $1.58B | $1.55B |
| Retained earnings | $946M | $953M | $1.08B | $715M | $782M | $866M | $939M | $1.02B | $1.09B | $1.09B |
| Shares (wtd avg diluted) | 59.7M | 57.5M | 54.5M | 54.1M | 54.6M | 55.2M | 53.6M | 51.8M | 50.1M | 47.6M |
Every figure is extracted from EDGEWELL PERSONAL CARE Co’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.